2016-11-14T19:53:50-06:00 2015-12-31 ERNST & YOUNG US LLP TWO NORTH CENTRAL AVENUE STE 2300 PHOENIX AZ 85004 990 2015-01-01 860098929 BLOOD SYSTEMS INC % SUSAN BARNES BLOO 4809464201 PO BOX 1867 SCOTTSDALE AZ 85252 SUSAN L BARNES EXECUTIVE VP & CFO 4809464201 2016-11-14 true BRENDA GRIESEMER P00264669 6023223000 2015 2017-02-10 21:41:12Z J DANIEL CONNOR SAME AS C ABOVE SCOTTSDALE AZ 85252 772736486 false 6167 X www.bloodsystems.org X 1943 AZ BLOOD BANKING, PLASMA DERIVATIVE DISTRIBUTION, AND RESEARCH 19 19 2877 1100 171758981 785626 8365565 7622066 488666748 578648022 5190677 48639119 -128815 4991255 502094175 639900462 235610 226593 0 0 176835161 171596686 0 0 0 350819704 437305133 527890475 609128412 -25796300 30772050 401630955 382520351 200115938 192026029 201515017 190494322 X SEE SCHEDULE O true false 259056955 226593 255156634 UNITED BLOOD SERVICES BLOOD BANKING - SEE SCHEDULE O 293562436 0 304884979 BIOCARE BIOLOGICALS - SEE SCHEDULE O 16112696 0 15625732 BLOOD SYSTEMS RESEARCH INSTITUTE - SEE SCHEDULE O 12150300 0 8067289 580882387 true true false false false false false false false true true false false false true true false true false false true false false false true false false true false true true false false false false false true false false true false true false false false false true true true false false true 462 0 true 2877 true true true true CJ false false false true true false false false false X 19 19 false false false false false false false true true false true true true true true true true true true true true true AZ CA X SUSAN BARNES 4806755696 6210 E OAK STREET SCOTTSDALE AZ 85257 X HEATHER ALLEN MD TRUSTEE 3.0 0.0 X 26000 0 0 James R Allen MD Trustee 3.0 0.0 X 24000 0 0 Linda Blessing PhD Trustee 3.0 1.0 X 30250 0 0 William A Dittman MD Trustee 2.0 1.0 X 21000 0 0 Armando B Flores Trustee 5.0 1.0 X 23500 0 0 Bill Gates Trustee 2.0 0.0 X 17000 0 0 William G Green Trustee 2.0 0.0 X 26500 0 0 Michael C Jensen Trustee 2.0 0.0 X 21000 0 0 F Leonard Johnson MD Trustee 2.0 0.0 X 18000 0 0 John Lewis Trustee/Chair 3.0 1.0 X X 50750 0 0 Pierre Noel MD Trustee 2.0 0.0 X 23000 0 0 James Peterson Trustee (AS OF 4/15) 2.0 0.0 X 16000 0 0 Kathleen S Pushor Trustee 3.0 0.0 X 23250 0 0 Antonio Ruiz Trustee (thru 11/15) 2.0 1.0 X 18000 0 0 Mark T Schieble Trustee 2.0 1.0 X 21000 0 0 Steven L Seiler Trustee (thru 4/15) 3.0 0.0 X 5250 0 0 Richard G Spurlock Trustee 2.0 0.0 X 21000 0 0 Paul E Stander MD Trustee 2.0 0.0 X 20000 0 0 Ron Waeckerlin MD Trustee/Vice Chair 3.0 1.0 X X 36000 0 0 Gary K Wilde Trustee/Secretary/Treasurer 3.0 1.0 X X 25250 0 0 Nancy L Wollen Trustee (as of 11/15) 2.0 1.0 X 0 0 0 J Daniel Connor President/CEO 38.0 2.0 X 672854 0 39344 Susan Barnes Executive VP and CFO 30.0 20.0 X 716067 0 21092 David Green Pres Blood Centers Division 40.0 0.0 X 513262 0 38317 Bhavi Shah EVP/General Counsel 30.0 10.0 X 242326 0 24425 Ralph Vassallo EVP Chief Med & Scient Offcr 40.0 0.0 X 469132 0 13833 Mary Beth Bassett EVP Chief Quality Officer 40.0 0.0 X 436023 0 35518 Michael Busch MD SVP Research & Scientific Prog 40.0 0.0 X 423100 0 38845 Tom Choi VP Inv Mngmt & Hosp Srvcs 40.0 0.0 X 211784 0 12687 Vicki Finson VP Corporate Integration 40.0 0.0 X 224204 0 18497 Dennis Harpool SVP Oper Policies & Processes 40.0 0.0 X 229445 0 20775 Robert Hartmann VP Info Technology 40.0 0.0 X 241477 0 23306 Hany Kamel MD VP Corporate Medical Director 40.0 0.0 X 340865 0 46142 Linda Matthews President BioCARE 40.0 0.0 X 485472 0 44963 PETER MICHAELSON VP HUMAN RESOURCES 40.0 0.0 X 275975 0 42437 Connie L Morris VP Manufacturing & Lab Srvs 40.0 0.0 X 180532 0 20480 Phillip Norris VP Research & Scientific Prog 40.0 0.0 X 259474 0 41056 Frank Nizzi MD VP Clinical Services 40.0 0.0 X 330851 0 20741 Paula Villalobos VP Field Operations 40.0 0.0 X 234534 0 12591 Charles E Wilcox III VP Ops/Blood Centers Division 40.0 0.0 X 263394 0 20688 Kevin Land MD Sr Medical Director 40.0 0.0 X 320414 0 20567 Andrew Kirk vp sales 40.0 0.0 X 281984 0 32785 pedro cano MD sr medical DIR (thru 12/2015) 40.0 0.0 X 277433 0 8917 ROBIN CUSICK CHIEF MEDICAL OFFICER 40.0 0.0 X 272590 0 30661 MARY TOWNSEND MD SR MEDICAL DIRECTOR 40.0 0.0 X 272349 0 33256 Patrick Holt EVP Business Services 40.0 0.0 X 358730 0 0 SALLY CAGLIOTI PRESIDENT CTS 0.0 40.0 X 0 1089016 36623 EUGENE Robertson PHD VICE PRESIDENT CTS 0.0 0.0 X 0 195212 34206 9001021 1284228 732752 200 true true false Manpower Inc 21271 NETWORK PLace CHICAGO IL 60673 CONSULTANT 2247096 mak systems 2720 river road suite 225 DES PLAINES IL 60018 CONSULTANT 1710824 aerotek 2689 collections center way CHICAGO IL 60693 CONSULTANT 1353849 TOLIN MECHANICAL SYSTEMS COMPANY 12005 EAST 45TH AVENUE DENVER CO 80239 MAINTENANCE SERVICE 1181359 Federal Express PO Box 7221 PASADENA CA 91109 DELIVERY SERVICE 1071651 49 X 5576 130716 2041311 5444463 5294229 7622066 PHARMACEUTICAL SALES 446110 305092002 133333021 171758981 BLOOD AND COMPONENTS SERVICE FEES 541900 235845924 235845924 PLASMA FOR FRACTIONATION 541900 12791492 12791492 LABORATORY SERVICES 621500 12623283 12623283 RESEARCH CONTRACTS 541700 10718774 10718774 1576547 1576547 578648022 3211529 3211529 0 21020 21020 0 0 0 178138226 -18797 132691839 45446387 -18797 45427590 45427590 27808 130716 144185 -116377 -116377 0 0 MISCELLANEOUS INCOME 900099 3827077 3827077 NON-OPERATING MISCELLANEOUS INCOME 900099 1259535 1259535 5086612 639900462 411975653 171758981 48543762 226593 226593 0 0 0 7279713 7279713 506438 89686 416752 125061605 107310387 17751218 9283416 10647772 -1364356 20657955 16348051 4309904 8807559 6740552 2067007 0 665633 665633 500983 500983 0 0 117887 117887 4204746 1312227 2892519 174352 174352 16601386 12634089 3967297 3738277 9025124 -5286847 0 12353916 11156867 1197049 11381128 9048813 2332315 0 0 1863717 1142 1862575 0 14690688 6440972 8249716 1234238 876489 357749 PHARM. PRODUCTS PURCHASED 286890074 286890074 OPERATING & TESTING SUPPLIES 76880957 76880957 DONOR RECOGNITION & PROMO 9787803 9787803 INCOME TAX 35950 35950 -3816602 15254487 -19071089 609128412 580882387 28246025 0 0 -8639484 126392934 87351623 0 0 80644268 122779113 150000 125000 0 0 6863645 5983051 61649285 69301188 8842694 6527770 205420753 139306659 79235672 66114094 27081572 25097431 9290011 6743105 0 0 480000 360000 1000874 777460 401630955 382520351 106814464 107239610 0 0 0 0 26175000 23620000 0 0 0 0 23417911 16014465 0 0 43708563 45151954 200115938 192026029 X 201515017 190494322 0 0 0 0 201515017 190494322 401630955 382520351 X 30772050 -50846004 847773 8205486 X false true X true true true X 7850022 9272139 8382904 8365565 7622066 41492696 485095730 483844494 476310348 488608480 583584663 2517443715 0 0 0 492945752 493116633 484693252 496974045 591206729 2558936411 0 0 0 2558936411 4163810 3987530 3621490 4295796 3232549 19301175 15544 47343 67686 47439 74585 252597 4179354 4034873 3689176 4343235 3307134 19553772 0 0 497125106 497151506 488382428 501317280 594513863 2578490183 0.99242 0.99226 0.00758 0.00773 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 26960483 483 -561129 1302406 25097431 29650105 1268538 3958160 26960483 27010166 3712762 1072823 29650105 25294973 2769261 1044881 9187 27010166 21171221 4060473 68277 0 4998 25294973 1.00000 0.00000 0.00000 false false 0 6802117 6802117 0 62013050 40160406 21852644 0 14003819 12510239 1493580 0 69647071 57807724 11839347 0 52954696 28828290 24126406 66114094 0 CURRENT LINE OF CREDIT 45000000 LONG TERM RENT STEP UP 147296 LT TENANT IMPROVEMENT ALLOWANCE 4658 45151954 X SCHEDULE D, PART V, LINE 4 THE BLOOD SYSTEMS BOARD RESTRICTED ENDOWMENT FUNDS ARE RESERVED FOR THE PURPOSES OF PROVIDING RESEARCH FUNDS TO BLOOD SYSTEMS RESEARCH INSTITUTE TO SUPPORT THE BLOOD TRANSFUSION RESEARCH EFFORTS OF THAT DIVISION. SCHEDULE D, PART X, LINE 2 AT DECEMBER 31, 2015, THE COMPANY EVALUATED WHETHER IT HAD UNCERTAIN TAX POSITIONS THAT SHOULD BE RECOGNIZED OR DERECOGNIZED BASED ON A 'MORE LIKELY THAN NOT' THRESHOLD FOR TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN, INCLUDING THOSE TAX POSITIONS THAT WOULD NOT BE SUSTAINED UPON EXAMINATION IN ACCORDANCE WITH GUIDANCE RELATED TO ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. THE TAX YEARS FOR THE COMPANY THAT ARE OPEN TO AUDIT BY THE IRS AND STATE DEPARTMENTS OF REVENUE ARE GENERALLY THE TAX YEARS ENDED DECEMBER 31, 2012, THROUGH THE CURRENT TAX YEAR EXCEPT IN CERTAIN STATES WHERE THE OPEN TAX YEARS GENERALLY BEGIN WITH THE TAX YEAR ENDED DECEMBER 31, 2011. AS OF DECEMBER 31, 2015, THE COMPANY HAS NOT IDENTIFIED ANY UNCERTAIN TAX POSITIONS THAT WOULD REQUIRE THE RECORDING OF A TAX LIABILITY. THE COMPANY DOES NOT ANTICIPATE A CHANGE IN UNCERTAIN TAX POSITIONS FOR THE 12 MONTHS FOLLOWING THE YEAR ENDED DECEMBER 31, 2015. Central America and the Caribbean Program Services CAPTIVE INSURANCE 534761 534761 534761 true false true false false false GALA 80094 74017 6077 17645 10682 25000 15978 LUNCHEON 36219 24459 11760 27366 7000 22479 2 42211 32240 9971 2345 3009 3009 9672 158524 130716 27808 19990 30375 20691 25000 48129 144185 -116377 true AMERICA'S BLOOD CENTERS 725 15TH STR NW STE 700 WASHINGTON DC 200052100 866052376 501(C)(6) 27500 2015 PLEDGE Support AMERICAN ASSOCIATION OF BLOOD BANKS 8101 GLENBROOK ROAD BETHESDA MD 20814 362384118 501(C)(3) 75000 CORD BLOOD PLEDGE GLOBAL BLOOD FUND 1001 N LINCOLN BLVD OKLAHOMA CITY OK 73104 392071848 501(C)(3) 10000 2015 PLEDGE Support FLIGHTS FOR LIFE PO BOX 26485 PHOENIX AZ 85068 742453899 501(C)(3) 16000 General Support 3 1 SCHEDULE I, PART I, LINE 2 SPONSORSHIPS AND DONATIONS TO OTHER TAX-EXEMPT ENTITIES ARE MADE IN SUPPORT OF THEIR MISSIONS AND ARE MONITORED VIA THE GOVERNANCE PRACTICES OF THOSE ENTITIES. X X X X true true false false false false false true false J Daniel Connor President/CEO 660704 0 0 0 12150 0 28600 0 10744 0 712198 0 0 0 Susan Barnes Executive VP and CFO 320595 0 0 0 395472 0 10600 0 10492 0 737159 0 384361 0 David Green Pres Blood Centers Division 394091 0 61875 0 57296 0 23364 0 14953 0 551579 0 0 0 Bhavi Shah EVP/General Counsel 216214 0 15000 0 11112 0 10113 0 14312 0 266751 0 0 0 Mary Beth Bassett EVP Chief Quality Officer 298959 0 125000 0 12064 0 28600 0 6918 0 471541 0 952 0 Michael Busch MD SVP Research & Scientific Prog 408868 0 0 0 14232 0 28600 0 10245 0 461945 0 4263 0 Tom Choi VP Inv Mngmt & Hosp Srvcs 201815 0 0 0 9969 0 6352 0 6335 0 224471 0 0 0 Vicki Finson VP Corporate Integration 223466 0 0 0 738 0 8086 0 10411 0 242701 0 0 0 Dennis Harpool SVP Oper Policies & Processes 219476 0 0 0 9969 0 3716 0 17059 0 250220 0 0 0 Robert Hartmann VP Info Technology 231508 0 0 0 9969 0 9489 0 13817 0 264783 0 0 0 Hany Kamel MD VP Corporate Medical Director 328916 0 0 0 11949 0 28600 0 17542 0 387007 0 1980 0 Linda Matthews President BioCARE 300364 0 170464 0 14644 0 28600 0 16363 0 530435 0 3532 0 PETER MICHAELSON VP HUMAN RESOURCES 266006 0 0 0 9969 0 28600 0 13837 0 318412 0 0 0 Connie L Morris VP Manufacturing & Lab Srvs 170563 0 0 0 9969 0 6849 0 13631 0 201012 0 0 0 Phillip Norris VP Research & Scientific Prog 259474 0 0 0 0 0 27681 0 13375 0 300530 0 0 0 Frank Nizzi MD VP Clinical Services 320882 0 0 0 9969 0 10600 0 10141 0 351592 0 0 0 Ralph Vassallo EVP Chief Med & Scient Offcr 341680 0 15000 0 112452 0 7950 0 5883 0 482965 0 0 0 Paula Villalobos VP Field Operations 224565 0 0 0 9969 0 6181 0 6410 0 247125 0 0 0 Charles E Wilcox III VP Ops/Blood Centers Division 253425 0 0 0 9969 0 10600 0 10088 0 284082 0 0 0 Patrick Holt EVP Business Services 57725 0 0 0 301005 0 0 0 0 0 358730 0 0 0 Kevin Land MD Sr Medical Director 320414 0 0 0 0 0 6686 0 13881 0 340981 0 0 0 Andrew Kirk vp sales 141614 0 88385 0 51985 0 7078 0 25707 0 314769 0 0 0 pedro cano MD sr medical DIR (thru 12/2015) 265984 0 0 0 11449 0 7950 0 967 0 286350 0 0 0 ROBIN CUSICK CHIEF MEDICAL OFFICER 272590 0 0 0 0 0 28500 0 2161 0 303251 0 0 0 MARY TOWNSEND MD SR MEDICAL DIRECTOR 272349 0 0 0 0 0 10600 0 22656 0 305605 0 0 0 SALLY CAGLIOTI PRESIDENT CTS 0 364615 0 96980 0 627421 0 28600 0 8023 0 1125639 0 616309 EUGENE Robertson PHD VICE PRESIDENT CTS 0 122561 0 68220 0 4431 0 25689 0 8517 0 229418 0 0 SCHEDULE J, PART I, LINE 4a PATRICK HOLT received severance payments of $300,593 during 2015. This amount is taxable and is included in Schedule J, Part II, Column b(III). SCHEDULE J, PART I, LINE 4B CERTAIN EMPLOYEES RECEIVED DISTRIBUTIONS FROM THE SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN DURING 2015 AS FOLLOWS: SALLY CAGLIOTI: $616,309 (RESULTING FROM ALMOST 27 YEARS OF SERVICE) MARY BETH BASSETT: $952 (RESULTING FROM ALMOST 20 YEARS OF SERVICE) MICHAEL BUSCH, MD: $4,263 (RESULTING FROM ALMOST 17 YEARS OF SERVICE) HANY KAMEL, MD: $1,980 (RESULTING FROM ALMOST 20 YEARS OF SERVICE) LINDA MATTHEWS: $3,532 (RESULTING FROM ALMOST 16 YEARS OF SERVICE) SUSAN L. BARNES: $384,361 (RESULTING FROM ALMOST 26 YEARS OF SERVICE) THESE AMOUNTS WERE INCLUDED IN TAXABLE WAGES AND ARE REPORTED IN SCHEDULE J, PART II, COLUMN B(III) AND ALSO IN COLUMN F SINCE THESE AMOUNTS HAVE PREVIOUSLY BEEN REPORTED AS DEFERRED COMPENSATION ON A PRIOR FORM 990. THIS PLAN WAS FROZEN AS OF DECEMBER 31, 2011. SCHEDULE J, PART I, LINE 7 BLOOD SYSTEMS HAS AN INCENTIVE BONUS PLAN FOR MANAGEMENT AND EXECUTIVES. AWARDS UNDER THE PROGRAM ARE AT THE DISCRETION OF THE BOARD OF TRUSTEES. THE PLAN MEASURES PERFORMANCE AGAINST MULTIPLE METRICS WHICH CARRY VARIOUS WEIGHTINGS, THE MOST HEAVILY WEIGHTED BEING QUALITY, SAFETY AND CUSTOMER SERVICE. TO ASSURE FINANCIAL STABILITY OF THE COMPANY, ONE OF THE METRICS IS ALSO A MEASUREMENT OF NET MARGIN FINANCIAL PERFORMANCE AS A PERCENT OF REVENUES. SCHEDULE J, PART II David Green, Ralph Vassallo, Andrew Kirk and Pedro Cano received payments for relocation expenses. This amount is taxable and is included in Schedule J, Part II, Column B(III). DAVID GREEN, BHAVI SHAH, RALPH VASSALLO, AND ANDREW KIRK RECIEVED HIRING BONUSES, WHICH ARE INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). MARY BETH BASSETT RECIEVED A RETRENTION BONUS, WHICH IS INCLUDED IN SCHEDULE J, PART II, COLUMN B(II). LINDA MATTHEWS IS THE PRESIDENT OF THE BIOCARE DIVISION OF BLOOD SYSTEMS. THIS DIVISION PERFORMED WELL ABOVE ITS BUDGETED EXPECTATION AND WAS GRANTED AN INCENTIVE BONUS UNDER THE COMPANY'S PLAN. A ARIZONA HEALTH FACILITIES AUTHORITY 860453292 2014-01-06 27005000 SEE PART VI false false false A 3385000 0 27005000 0 0 0 41114 0 0 26963886 0 0 2014 true false true true A false false false true false 0.00000 0.00700 0.00700 false false 0.00000 false true A false true false false 0 false 0 false true A true . Schedule K, Part I, Line A, Column F REFUNDING OF AHFA 2004 BOND ISSUE WHICH WAS USED FOR THE PURCHASE OF LAND AND TO CONSTRUCT AND EQUIP 11 BLOOD CENTERS IN VARIOUS STATES FOR THE PURPOSE OF RECRUITING, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD PRODUCTS; REFUNDING OF ABAG 2002 BOND ISSUE USED TO CONSTRUCT A BLOOD CENTER IN SAN FRANCISCO, CA; AND, REFUNDING OF AHFA 1995 VARIABLE RATE BOND ISSUE USED TO CONSTRUCT AND EQUIP A NATIONAL BLOOD TESTING LABORATORY IN TEMPE, ARIZONA. DAVID GREEN OFFICER HOUSE X 150000 125000 false true true 125000 orrin h camp spouse of officer 89686 COMPENSATION - BSI EMPLOYEE false X RECOGNITION 352 5275493 COST/SELLING PRICE X REFRESHMENT 63 18313 COST/SELLING PRICE X OTHER 4 423 COST/SELLING PRICE 0 false true false SCHEDULE M, PART I, COLUMN (B) THE ORGANIZATION IS REPORTING THE NUMBER OF CONTRIBUTIONS RECEIVED IN COLUMN (B). FORM 990, PART III, LINE 1 THE MISSION OF BLOOD SYSTEMS, INC. ("BSI") IS TO MAKE A DIFFERENCE IN PEOPLE'S LIVES BY BRINGING TOGETHER THE BEST PEOPLE, INSPIRING INDIVIDUALS TO DONATE BLOOD, PRODUCING A SAFE AND AMPLE BLOOD SUPPLY, ADVANCING CUTTING-EDGE RESEARCH AND EMBRACING CONTINUOUS QUALITY IMPROVEMENT. TO FURTHER ITS MISSION, BSI OPERATES 17 COMMUNITY BLOOD CENTERS. THESE CENTERS RECRUIT BLOOD DONORS AND COLLECT, PROCESS AND DISTRIBUTE APPROXIMATELY 860,000 BLOOD DONATIONS TO MEET THE BLOOD NEEDS OF PATIENTS IN MORE THAN 500 HOSPITALS THROUGHOUT THE COUNTRY. THE STAFF OF NEARLY 2,300 SERVES A GEOGRAPHIC AREA COVERING THE UNITED STATES, FROM THE EAST COAST TO CALIFORNIA AND FROM THE CANADIAN BORDER TO MEXICO. BSI IS KNOWN MORE COMMONLY THROUGHOUT THE UNITED STATES BY THE NAME OF ITS BLOOD BANKING DIVISION, UNITED BLOOD SERVICES. BSI IS LICENSED BY THE U.S. FOOD AND DRUG ADMINISTRATION ("FDA") AS A PROVIDER OF BLOOD AND BLOOD SERVICES. THE COMPANY'S THREE OPERATING DIVISIONS ARE: (1) THE BLOOD BANKING DIVISION, WHICH INCLUDES UNITED BLOOD SERVICES; (2) THE BIOCARE DIVISION; AND (3) THE BLOOD SYSTEMS RESEARCH INSTITUTE. THESE OPERATING DIVISIONS ARE UNINCORPORATED DIVISIONS DOING BUSINESS UNDER REGISTERED TRADENAMES AND SERVICE MARKS. BSI CONDUCTS ITS BLOOD BANKING ACTIVITIES THROUGH ITS REGIONAL BLOOD CENTERS LOCATED IN THE FOLLOWING STATES: ARIZONA, CALIFORNIA, COLORADO, LOUISIANA, MISSISSIPPI, MONTANA, NEVADA, NEW MEXICO, NORTH DAKOTA, SOUTH DAKOTA, TEXAS, OHIO, NEW JERSEY, AND WYOMING. THE BIOCARE DIVISION DISTRIBUTES PLASMA-DERIVED PRODUCTS THROUGH HOSPITALS, COMMUNITY BLOOD CENTER LOCATIONS AND ALSO DIRECTLY FROM ITS HEADQUARTERS IN TEMPE, ARIZONA. BLOOD-RELATED RESEARCH IS CONDUCTED AT THE BLOOD SYSTEMS RESEARCH INSTITUTE LOCATED IN SAN FRANCISCO, CALIFORNIA. FORM 990, PART III, LINE 2 ON JANUARY 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH LIFESHARE COMMUNITY BLOOD SERVICES, INC ("lIFESHARE"). LIFESHARE IS A COMMUNITY-FOCUSED NONPROFIT ORGANIZATION COMMITTED TO PROVIDING A SAFE AND ADEQUATE BLOOD SUPPLY AND COMPONENT SUPPLY FOR PATIENT HEALTHCARE IN NORTHEAST OHIO. ON FEBRUARY 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH BERGEN COMMUNITY REGIONAL BLOOD CENTER, INC ("cOMMUNITY BLOOD SERVICES"). COMMUNITY BLOOD SERVICES PROMOTeS THE HEALTH OF THE COMMUNITY BY PROVIDING HIGH-QUALITY BLOOD AND TISSUE SERVICES. ON NOVEMBER 1, 2015 BSI EFFECTED A MEMBER SUBSTITUTION (ACQUIRED) WITH MID-SOUTH REGIONAL BLOOD CENTER, INC ("MID-SOUTH"). MID-SOUTH IS A COMMUNITY-FOCUSED NONPROFIT ORGANIZATION COMMITTED TO PROVIDING A SAFE AND ADEQUATE BLOOD SUPPLY FOR PATIENT HEALTHCARE IN THE MID-SOUTH REGION. FORM 990, PART III, LINES 4A-D 4A) UNITED BLOOD SERVICES - BLOOD BANKING THE BLOOD BANKING DIVISION OPERATES UNDER THE NAME UNITED BLOOD SERVICES ("UBS"). THE PRIMARY PURPOSE OF UBS IS TO PROVIDE A SAFE AND STABLE SUPPLY OF BLOOD AND BLOOD COMPONENTS TO HOSPITALS AND MEDICAL FACILITIES. THE STRENGTH OF UBS IS THAT IT OPERATES AS LOCAL BLOOD CENTERS THAT ARE PART OF THE COMMUNITY AND YET HAS ACCESS TO A LARGE NETWORKED ORGANIZATION WITH ALL THE ADVANTAGES AND EFFICIENCIES THAT ARE REALIZED THROUGH STANDARDIZATION AND ECONOMIES OF SCALE. UBS COLLECTS BLOOD FROM VOLUNTEER DONORS, PERFORMS SCREENING AND TESTING ON THE DONATED BLOOD, AND PROCESSES THE WHOLE BLOOD INTO BLOOD COMPONENTS SUCH AS RED CELLS, PLATELETS AND PLASMA. BLOOD AND BLOOD COMPONENTS ARE THEN STORED AND DISTRIBUTED TO HOSPITALS AND OTHER HEALTH CARE PROVIDERS. 4B) BIOCARE - BIOLOGICALS THE BIOCARE DIVISION PROVIDES BIOLOGICAL PRODUCTS, BOTH HUMAN-PLASMA DERIVED AND RECOMBINANT PRODUCTS, THAT SERVE AS ADJUNCT THERAPIES IN TRANSFUSION MEDICINE AND HEALTHCARE. PLASMA DERIVATIVES ARE BASICALLY PROTEIN THERAPIES PROVIDED FROM PLASMA LEFT OVER FROM WHOLE BLOOD DONATIONS. EXAMPLES OF SUCH PLASMA DERIVATIVES INCLUDE: INTRAVENOUS IMMUNE GLOBULINS, COAGULATION FACTORS, ALBUMIN AND FIBRIN SEALANTS. THESE PRODUCTS ARE USED AS THERAPIES FOR IMMUNE SYSTEM DISORDERS, BLEEDING DISORDERS AND WOUND MANAGEMENT. RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. RECOMBINANT-BASED PRODUCTS ARE OFTEN STABILIZED WITH ALBUMIN (CONCENTRATE OF PLASMA PROTEINS FROM HUMAN PLASMA), BUT THESE PRODUCTS ARE NOT MANUFACTURED FROM HUMAN PLASMA. THESE RECOMBINANT PRODUCTS, SIMILAR TO THE PLASMA-DERIVATIVE PRODUCTS, ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. 4C) BLOOD SYSTEMS RESEARCH INSTITUTE BLOOD SYSTEMS RESEARCH INSTITUTE ("BSRI") FACILITATES RESEARCH PRIMARILY FUNDED BY EXTRAMURAL GRANTS (NIH AND OTHERS). THE RESEARCH IS IN TRANSFUSION MEDICINE EPIDEMIOLOGY, HEALTH POLICY, VIROLOGY, VIRAL DISCOVERY, THE IMMUNE REACTION TO TRANSFUSION AND TO TRANSFUSION-TRANSMITTED INFECTIOUS AGENTS, CELL THERAPY AND GENETIC EPIDEMIOLOGY. AREAS STUDIED INCLUDE IMPLICATIONS OF RECEIVING COMPONENTS AT DIFFERENT STORAGE AGES; MECHANISM OF VIRUS ENTRY INTO CELLS; HOW TRANSFUSION TRANSMITTED VIRUSES CAUSE SYMPTOMS; THE USE OF COMMERCIALLY AVAILABLE OR LOCALLY-DEVELOPED DONOR TESTS; THE FACTORS LEADING TO CHIMERISM, ETC. BSRI SUPPORTS TRAINING PROGRAMS FOR SPECIALISTS IN TRANSFUSION MEDICINE AND THE DEVELOPMENT OF EPIDEMIOLOGY RESEARCH SCIENTISTS. BSRI INVESTIGATORS PUBLISH MORE THAN 45 PAPERS EACH YEAR IN THE PEER-REVIEWED SCIENTIFIC LITERATURE. THE RESEARCH FACILITY IS STAFFED WITH 12 INVESTIGATORS, 24 RESEARCH ASSOCIATES, 16 STAFF SCIENTISTS AND VARIOUS OTHER POSITIONS AS WELL AS ADMINISTRATIVE SUPPORT. 4D) OTHER PROGRAM SERVICES CONSIST OF LABORATORY SERVICES AND OTHER PROGRAM ACTIVITIES. FORM 990, PART VI, LINE 1A THE EXECUTIVE COMMITTEE HAS THE POWERS OF THE BOARD OF TRUSTEES BETWEEN BOARD MEETINGS, UNLESS PROHIBITED BY LAW OR THE ARTICLES OF INCORPORATION. THE EXECUTIVE COMMITTEE IS COMPOSED OF 6 OR MORE TRUSTEES, INCLUDING THE CHAIR, VICE CHAIR, SECRETARY-TREASURER, ONE TRUSTEE SELECTED BY BLOOD CENTERS OF THE PACIFIC, AND TWO OR MORE TRUSTEES SELECTED BY THE BOARD. FORM 990, PART VI, LINE 11B THE FORM 990 IS REVIEWED BY MANAGEMENT, INCLUDING CONFIRMATION OF COMPENSATION DISCLOSURES AGAINST W-2 AND 1099 REPORTING. A COPY OF THE DRAFT FORM 990 AND ALL SCHEDULES IS SUPPLIED TO ALL BOARD MEMBERS PRIOR TO THE MEETING HELD TO ACCEPT THE RETURNS. THE W-2S AND 1099S ARE AVAILABLE FOR BOARD REVIEW UPON REQUEST. THE PAID PREPARER, ERNST & YOUNG, AND MEMBERS OF MANAGEMENT REVIEW THE FORM 990 WITH THE COMMITTEES AND ARE AVAILABLE FOR ANSWERING QUESTIONS. ANY COMMENTS FROM THE BOARD ARE CONSIDERED PRIOR TO FILING WITH THE IRS. FORM 990, PART VI, LINE 12C EACH YEAR, THE BOARD OF TRUSTEES AND SENIOR MANAGEMENT ARE REQUIRED TO SIGN AND RETURN A CONFLICT OF INTEREST FORM TO COMPANY COUNSEL. ANY CONFLICTS DISCLOSED ARE DISCUSSED IN EXECUTIVE SESSION WITH THE BOARD AND RESOLVED. IN ADDITION, IN PREPARATION FOR THE FORM 990 FILING, THE TRUSTEES, OFFICERS AND KEY EMPLOYEES IDENTIFIED ARE REQUIRED TO RESPOND TO A COMPREHENSIVE CONFLICT OF INTEREST AND FAMILY RELATIONSHIP QUESTIONNAIRE. ANY CONFLICTS DISCLOSED ARE DISCUSSED WITH THE BOARD AND DISCLOSED APPROPRIATELY ON THE FORM 990. FORM 990, PART VI, LINES 15A AND 15B THE BOARD OF TRUSTEES HAS A COMPENSATION AND HUMAN RESOURCE COMMITTEE WHOSE PURPOSE, AMONG OTHER THINGS, IS TO HIRE AN INDEPENDENT CONSULTING FIRM ONCE EVERY 2-3 YEARS TO PROVIDE DATA ON COMPETITIVENESS OF SALARIES AND BENEFITS FOR THE CEO AND OTHER OFFICERS OF THE CORPORATION. THE MEMBERS OF THE HUMAN RESOURCE AND COMPENSATION COMMITTEE OF THE BOARD ARE ALL INDEPENDENT TRUSTEES AND INCLUDE NO MEMBERS OF MANAGEMENT. THE RECOMMENDATIONS OF THE COMMITTEE ARE REVIEWED BY THE ENTIRE BOARD PRIOR TO APPROVAL. COMPENSATION FOR THESE INDIVIDUALS IS SET AND APPROVED BY THE BOARD EACH YEAR. THE RESULTS OF THESE DISCUSSIONS, REVIEWS AND APPROVALS ARE DOCUMENTED IN THE EXECUTIVE MINUTES OF THE BOARD MEETINGS. THIS PROCESS WAS LAST COMPLETED IN 2015. FORM 990, PART VI, LINE 19 THE FORM 990 IS MADE AVAILABLE ON THE COMPANY'S INTRA-NET FOR ALL OPERATING LOCATIONS TO ACCESS. UPON REQUEST, THE FORM CAN BE PRINTED OR VIEWED ON-LINE. UPON WRITTEN REQUEST TO THE CHIEF FINANCIAL OFFICER, A COPY OF THE FORM 990 WILL BE MAILED TO THE REQUESTOR. THE FORM 990 FOR CURRENT AND PAST YEARS IS ALSO POSTED ON GUIDESTAR FOR ORGANIZATIONS TO ACCESS. THE GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE NOT MADE AVAILABLE TO THE PUBLIC. THE ORGANIZATION'S COMBINED FINANCIAL STATEMENTS ARE MADE PUBLIC VIA THE ANNUAL REPORT POSTED ON THE ORGANIZATION'S WEBSITE. FORM 990, PART VII IN 2012, SALLY CAGLIOTI AND EUGENE ROBERTSON WERE REPORTED AS AN OFFICER AND KEY EMPLOYEE, RESPECTIVELY, OF BLOOD SYSTEMS, INC. ("BSI"). CREATIVE TESTING SOLUTIONS ("CTS"), A RELATED 501(C)(3) ORGANIZATION, LEASED THEIR EMPLOYEES FROM BSI IN 2012, INCLUDING SALLY CAGLIOTI AND EUGENE ROBERTSON. IN 2013 CTS HIRED THEIR OWN EMPLOYEES, INCLUDING SALLY CAGLIOTI AND EUGENE ROBERTSON. THUS, THEY ARE NO LONGER CONSIDERED AN OFFICER OR KEY EMPLOYEE OF BSI. FOR THIS REASON, THEY ARE BEING REPORTED AS FORMER. FORM 990, PART VIII, LINE 2A AS DESCRIBED IN THE NARRATIVE FOR PART III, LINE 4B, BIOCARE IS A DIVISION OF BLOOD SYSTEMS INC. THE BIOCARE DIVISION WAS CONCEIVED TO PROVIDE BLOOD BANK REAGENTS AND TRANSFUSION MEDICINE-RELATED, PLASMA-DERIVED PHARMACEUTICAL DERIVATIVES TO EXISTING HOSPITAL CUSTOMERS AS A CONVENIENT, VALUE-ADDED SERVICE. CURRENTLY, BIOCARE FUNCTIONS AS A SPECIALTY DISTRIBUTOR OF THERAPEUTIC PLASMA-DERIVATIVE PRODUCTS AND, INCREASINGLY, RECOMBINANT-BASED PRODUCTS TO BLOOD SYSTEMS TRADITIONAL CUSTOMER BASE OF HOSPITALS, AS WELL AS OUT-PATIENT SURGERY CENTERS, SPECIALTY PHARMACIES AND PHYSICIAN PRACTICES. THE MAJORITY OF PRODUCTS SOLD ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD-BORNE MEDICAL CONDITIONS. ALL OF THE PRODUCTS SOLD BY BIOCARE ARE MANUFACTURED BY COMMERCIAL BIO-PHARMACEUTICAL COMPANIES. THE SIGNIFICANT DIFFERENCE BETWEEN BIOCARE AND ITS FOR-PROFIT COMPETITORS IN TERMS OF PRICING IS THAT IN THE EVENT THERE IS A SHORTAGE OF CERTAIN PRODUCT, THE FOR-PROFIT COMPETITORS MAY RAISE THEIR PRICING UP TO TWO OR THREE TIMES NORMAL PRICING, WHILE BIOCARE MAINTAINS ITS PRICING VERY CLOSE TO ORIGINAL LEVELS, ONLY INCREASING PRICING TO OFFSET INCREASED ACQUISITION COSTS. THE REASON BIOCARE HAS TAKEN THIS APPROACH IS DUE TO BSIS EXEMPT PURPOSE TO DELIVER PRODUCTS FOR TRANSFUSION AND TREATMENT PURPOSES. BIOCARE ALSO DIFFERS FROM ITS FOR-PROFIT COMPETITORS IN THAT BIOCARES DISTRIBUTION SERVICES OFFER SAME-DAY AND STAT DELIVERY OPTIONS OVER THE WEEKEND OR AFTER HOURS FOR A MUCH LOWER COST THAN ITS FOR-PROFIT COMPETITORS. BIOCARE REPRESENTS THE FASTEST POSSIBLE OPTION OF GETTING LIFE-SAVING PLASMA-DERIVED AND RECOMBINANT-BASED PRODUCTS TO ITS TRADITIONAL CUSTOMER BASE OVER THE WEEKEND (FRIDAY, SATURDAY AND SUNDAY). MOST FOR-PROFIT COMPETITORS DO PROVIDE 24 HOUR ORDERING SERVICES; HOWEVER, UNLESS AN ORDER IS RECEIVED PRIOR TO THE CLOSE OF BUSINESS ON THURSDAY, THE PRODUCT WILL NOT BE DELIVERED UNTIL THE FOLLOWING WEEK. BIOCARE ALSO USES APPROXIMATELY 20 ORDERING LOCATIONS (FACILITIES) NATIONWIDE THAT ARE CAPABLE OF STORING AND DISTRIBUTING PRODUCT, WHILE MOST COMPETITORS ONLY HAVE A FEW. IT SHOULD BE NOTED THAT THE ACTIVITIES UNDERTAKEN BY BLOOD SYSTEMS RELATED TO ITS EXEMPT PURPOSES AS A WHOLE ARE SUBSTANTIAL AS COMPARED TO THE ACTIVITIES OF THE BIOCARE DIVISION. WHILE BIOCARE COMPRISES A SIGNIFICANT PORTION OF BSIS OVERALL REVENUE, THE NUMBER OF EMPLOYEES (APPROXIMATELY 43) AND HOURS PRODUCING THIS REVENUE IS VERY SMALL, AS COMPARED TO THE TOTAL NUMBER OF BSI EMPLOYEES (APPROXMATELY 2,800) AND HOURS PRODUCING THE RELATED EXEMPT PURPOSE REVENUE. PLASMA-DERIVATIVE PRODUCTS TREATED AS RELATED (COL B) - PLASMA-DERIVATIVE PRODUCTS ARE PRODUCTS THAT ARE MANUFACTURED FROM PROTEINS FOUND IN HUMAN PLASMA AND ARE USED TO TREAT DISEASES AND MEDICAL CONDITIONS THAT ARE CONNECTED WITH OR RELATED TO BLOOD OR BLOOD BORNE MEDICAL CONDITIONS. IT IS BLOOD SYSTEMS POSITION THAT PROVIDING BLOOD-DERIVED PRODUCTS, WHICH ARE MANUFACTURED BY BIO-PHARMACEUTICAL COMPANIES USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS FOR USE IN TREATING MEDICAL CONDITIONS OF PATIENTS IS DIRECTLY RELATED TO BLOOD SYSTEMS EXEMPT PURPOSES. AS THE PRODUCTS SOLD ARE MADE FROM AND CONTAIN HUMAN BLOOD/PLASMA AND PROTEIN, THERE IS A SUBSTANTIAL NEXUS BETWEEN THE SALE OF THESE PRODUCTS AND BLOOD SYSTEMS EXEMPT PURPOSES. IT SHOULD BE NOTED THAT OTHER NON-PROFIT COMPETITORS ALSO TREAT SIMILAR REVENUE AS RELATED, THUS MAKING IT AN INDUSTRY STANDARD. ACCORDINGLY, THE SALE OF PLASMA-DERIVATIVE PRODUCTS IS BEING TREATED AS RELATED REVENUE (SEE PART VIII, LINE 2A, COLUMN (B)). RECOMBINANT-BASED PRODUCTS TREATED AS UNRELATED (COL C) - RECOMBINANT-BASED PRODUCTS ARE PRODUCTS THAT ARE NOT MADE FROM FRACTIONATED HUMAN PLASMA. INSTEAD, THESE PRODUCTS ARE GENETICALLY ENGINEERED. THE RESULTING PRODUCT HAS THE STRUCTURAL AND FUNCTIONAL CHARACTERISTICS SIMILAR TO THE COMPONENT FOUND IN HUMAN PLASMA (OR BASED ON A PROTEIN IN HUMAN PLASMA) THAT THE DRUG WAS SYNTHESIZED TO IMITATE. IT IS BSIS POSITION THAT THE PROVISION OF RECOMBINANT-BASED DRUG PRODUCTS, WHICH ARE MANUFACTURED THROUGH GENETIC ENGINEERING BY BIO-PHARMACEUTICAL COMPANIES NOT USING HUMAN BLOOD/PLASMA, TO HOSPITALS AND OTHER HEALTHCARE PROVIDERS USED TO TREAT MEDICAL CONDITIONS IS NOT DIRECTLY RELATED TO BLOOD SYSTEMS PURPOSES. ACCORDINGLY, THE SALE OF RECOMBINANT-BASED PRODUCTS IS BEING TREATED AS UNRELATED BUSINESS INCOME (SEE PART VIII, LINE 2A, COLUMN (C)). DUE TO THE GROWTH IN AND EXPANSION OF THE BIOCARE DIVISION, AND THE POSITION RECENTLY TAKEN TO TREAT RECOMBINANT PRODUCTS AS UNRELATED BUSINESS INCOME, BLOOD SYSTEMS INC. FORMED BIOCARE, INC., AN ARIZONA FOR-PROFIT C CORPORATION EFFECTIVE SEPTEMBER 15, 2016. IT IS INTENDED THAT THE BIOCARE DIVISION OF BLOOD SYSTEMS, INC., IN ITS ENTIRETY, WILL BE TRANSFERRED TO AND OPERATED BY BIOCARE, INC. EFFECTIVE JANUARY 1, 2017. FORM 990, PART XI, LINE 9 CTS DISTRIBUTION OF EARNINGS $ 6,500,000 CSIC DISTRIBUTION OF EARNINGS $ 5,000,000 PENSION RECAPTURE EXP OTHER THAN NET PERIODIC COST $(3,294,514) ----------- TOTAL $ 8,205,486 CREATIVE TESTING SOLUTIONS 6210 EAST OAK STREET SCOTTDALE AZ 85257 271120123 SAFETY TEST. AZ 501(C)(3) 10 BSI true BLOOD CENTERS OF THE PACIFIC 270 MASONIC AVENUE SAN FRANCISCO CA 94118 941156555 BLOOD BANKING CA 501(C)(3) 9 BSI true INLAND NORTHWEST BLOOD CENTER 210 W CATALDO AVENUE SPOKANE WA 99201 910499130 BLOOD BANKING WA 501(C)(3) 9 BSI true BLOOD CENTER FND OF THE INLAND NORTHWEST 210 W CATALDO AVENUE SPOKANE WA 99201 464347438 FUNDRAISING WA 501(C)(3) 7 INBC true BELLE BONFILS MEMORIAL BLOOD CENTER 717 YOSEMITE STREET DENVER CO 80230 840411209 BLOOD BANKING CO 501(C)(3) 9 BSI true BONFILS BLOOD CENTER FOUNDATION 717 YOSEMITE STREET DENVER CO 80230 742787586 FUNDRAISING CO 501(C)(3) 7 BBMBC true BLOOD BANK OF SAN BERNARDINO & RIVERSIDE PO BOX 1429 SAN BERNARDINO CA 92402 951708743 BLOOD BANKING CA 501(C)(3) 9 BSI true BLOOD BANK SAN BERNARDINORIVERSIDE FDN PO BOX 1429 SAN BERNARDINO CA 92402 208911074 FUNDRAISING CA 501(C)(3) 11-TYPE I BBSBRC true MID-SOUTH REGIONAL BLOOD CENTER INC 1040 MADISON AVENUE MEMPHIS TN 38104 620719021 BLOOD BANKING TN 501(C)(3) 9 BSI true IT SYNERGISTICS LLC 115 TREE ST FLOWOOD MS 39232 202570319 SOFTWARE DEV. MS LS & BCRBC RELATED 0 0 false 0 false 0.00000 CANYON STATE INSURANCE COMPANY WEST BAY ROAD GRAND CAYMAN CJ 981084327 INVESTMENT CJ BSI FOREIGN 9045046 27629825 1.00000 true TRANSFUSION TECHNOLOGY INC 102 CHESTNUT RIDGE ROAD MONTVALE NJ 07645 223494865 INACTIVE NJ BCRBC C CORP 0 0 0.00000 true true false true false false true true true false true true true true false false true true true true BLOOD CENTERS OF THE PACIFIC C 399326 ACCRUAL BLOOD CENTERS OF THE PACIFIC G 3488226 ACCRUAL BLOOD CENTERS OF THE PACIFIC H 126615 ACCRUAL BLOOD CENTERS OF THE PACIFIC K 1616582 ACCRUAL BLOOD CENTERS OF THE PACIFIC L 3103464 ACCRUAL BLOOD CENTERS OF THE PACIFIC M 186289 ACCRUAL BLOOD CENTERS OF THE PACIFIC Q 296849 ACCRUAL BLOOD CENTERS OF THE PACIFIC S 293813 ACCRUAL CANYON STATE INSURANCE COMPANY F 5000000 ACCRUAL CANYON STATE INSURANCE COMPANY R 534761 ACCRUAL CREATIVE TESTING SOLUTIONS M 30993748 ACCRUAL CREATIVE TESTING SOLUTIONS L 5981821 ACCRUAL CREATIVE TESTING SOLUTIONS A 1108506 ACCRUAL CREATIVE TESTING SOLUTIONS J 1554338 ACCRUAL CREATIVE TESTING SOLUTIONS C 1084804 ACCRUAL CREATIVE TESTING SOLUTIONS Q 277727 ACCRUAL CREATIVE TESTING SOLUTIONS S 6500000 ACCRUAL INLAND NORTHWEST BLOOD CENTER H 625953 ACCRUAL INLAND NORTHWEST BLOOD CENTER L 1639318 ACCRUAL INLAND NORTHWEST BLOOD CENTER Q 92563 ACCRUAL INLAND NORTHWEST BLOOD CENTER P 112500 ACCRUAL INLAND NORTHWEST BLOOD CENTER C 83204 ACCRUAL belle BONFILS memorial BLOOD CENTER G 128718 ACCRUAL belle BONFILS memorial BLOOD CENTER H 614634 ACCRUAL belle BONFILS memorial BLOOD CENTER L 1435429 ACCRUAL belle BONFILS memorial BLOOD CENTER M 127599 ACCRUAL belle BONFILS memorial BLOOD CENTER Q 516878 ACCRUAL belle BONFILS memorial BLOOD CENTER C 110000 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE G 12879205 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE H 751314 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE L 1231717 ACCRUAL BLOOD BANK OF SAN BERNARDINO & RIVERSIDE Q 476017 ACCRUAL LIFESHARE community blood services G 1464268 ACCRUAL LIFESHARE community blood services H 116542 ACCRUAL LIFESHARE community blood services L 464350 ACCRUAL LIFESHARE community blood services Q 131694 ACCRUAL LIFESHARE community blood services C 129472 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER G 871690 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER L 240628 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER Q 131493 ACCRUAL BERGEN COMMUNITY REGIONAL BLOOD CENTER C 234504 ACCRUAL Mid-South Regional Blood CenteR INC Q 105965 ACCRUAL